Free Trial
→ Watch This Robotics Demo Before March 17th (From Brownstone Research) (Ad) Free BIIB Stock Alerts

Biogen (BIIB) Short Interest Ratio & Short Volume

Biogen logo
$140.64 +3.56 (+2.60%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$140.62 -0.02 (-0.02%)
As of 02/21/2025 07:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Biogen Short Interest Data

Biogen (BIIB) has a short interest of 3.74 million shares, representing 2.59% of the float (the number of shares available for trading by the public). This marks a -0.80% decrease in short interest from the previous month. The short interest ratio (days to cover) is 2.5, indicating that it would take 2.5 days of the average trading volume of 1.45 million shares to cover all short positions.

Current Short Interest
3,740,000 shares
Previous Short Interest
3,770,000 shares
Change Vs. Previous Month
-0.80%
Dollar Volume Sold Short
$538.30 million
Short Interest Ratio
2.5 Days to Cover
Last Record Date
January 31, 2025
Outstanding Shares
146,380,000 shares
Float Size
144,540,000 shares
Short Percent of Float
2.59%
Today's Trading Volume
1,807,566 shares
Average Trading Volume
1,448,624 shares
Today's Volume Vs. Average
125%
Short Selling Biogen?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Biogen and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

BIIB Short Interest Over Time

BIIB Days to Cover Over Time

BIIB Percentage of Float Shorted Over Time

Biogen Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
1/31/20253,740,000 shares $538.30 million -0.8%2.6%2.5 $143.93
1/15/20253,770,000 shares $531.57 million +2.5%2.6%2.5 $141.00
12/31/20243,680,000 shares $562.75 million +42.6%2.5%2.5 $152.92
12/15/20242,580,000 shares $387.08 million -5.2%1.8%1.7 $150.03
11/30/20242,720,000 shares $436.91 million +0.7%1.9%1.9 $160.63
11/15/20242,700,000 shares $431.97 million -13.5%1.9%2 $159.99
10/31/20243,120,000 shares $542.88 million +1.6%2.2%2.7 $174.00
10/15/20243,070,000 shares $588.06 million +7.7%2.1%2.8 $191.55
9/30/20242,850,000 shares $552.44 million -22.3%2.0%2.7 $193.84
9/15/20243,670,000 shares $717.96 million +9.9%2.5%3.6 $195.63
8/31/20243,340,000 shares $683.90 million +24.6%2.3%3.4 $204.76
8/15/20242,680,000 shares $540.37 million -1.8%1.9%2.6 $201.63
7/31/20242,730,000 shares $582.04 million -24.8%1.9%2.6 $213.20
7/15/20243,630,000 shares $804.34 million +32.5%2.5%3.4 $221.58
6/30/20242,740,000 shares $635.19 million -10.8%1.9%2.5 $231.82
6/15/20243,070,000 shares $711.29 million +1.7%2.1%2.7 $231.69
5/31/20243,020,000 shares $679.32 million -13.2%2.1%2.5 $224.94
5/15/20243,480,000 shares $818.91 million +10.5%2.4%2.9 $235.32
4/30/20243,150,000 shares $676.68 million -3.4%2.2%2.4 $214.82
4/15/20243,260,000 shares $641.57 million -8.2%2.3%2.7 $196.80
3/31/20243,550,000 shares $765.49 million +33.5%2.5%3 $215.63
3/15/20242,660,000 shares $583.36 million -5.0%1.8%2.4 $219.31
2/29/20242,800,000 shares $607.57 million -9.7%1.9%2.4 $216.99
2/15/20243,100,000 shares $692.39 million +1.3%2.2%2.8 $223.35
1/31/20243,060,000 shares $754.78 million -18.6%2.1%2.9 $246.66
1/15/20243,760,000 shares $932.93 million -3.8%2.6%3.4 $248.12
12/31/20233,910,000 shares $1.01 billion +32.5%2.7%3.6 $258.77
12/15/20232,950,000 shares $731.98 million +4.2%2.1%2.7 $248.13
11/30/20232,830,000 shares $662.45 million +7.6%2.0%2.9 $234.08
11/15/20232,630,000 shares $603.93 million -2.2%1.8%2.8 $229.63
10/31/20232,690,000 shares $638.98 million +1.9%1.9%3 $237.54
10/15/20232,640,000 shares $692.37 million -7.7%1.8%2.8 $262.26
9/30/20232,860,000 shares $735.05 million -10.9%2.0%3 $257.01
9/15/20233,210,000 shares $817.88 million +2.2%2.2%3.2 $254.79
8/31/20233,140,000 shares $839.51 million +3.6%2.2%2.9 $267.36
8/15/20233,030,000 shares $818.77 million -11.4%2.1%2.7 $270.22
7/31/20233,420,000 shares $924.05 million +33.1%2.4%3.1 $270.19
7/15/20232,570,000 shares $716.85 million +24.2%1.8%2.2 $278.93
6/30/20232,070,000 shares $589.64 million -7.2%1.4%2 $284.85
6/15/20232,230,000 shares $664.16 million -11.9%1.6%2.3 $297.83
Collect $7k per month from Tesla’s SECRET dividend (Ad)

There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?

Click here to uncover Tesla's hidden income secret.
5/31/20232,530,000 shares $749.92 million -14.5%1.8%2.7 $296.41
5/15/20232,960,000 shares $923.14 million +30.4%2.1%3.3 $311.87
4/30/20232,270,000 shares $690.60 million +13.5%1.6%2.4 $304.23
4/15/20232,000,000 shares $576.26 million -2.4%1.4%2.4 $288.13
3/31/20232,050,000 shares $569.96 million +3.5%1.4%2.2 $278.03
3/15/20231,980,000 shares $519.49 million +7.0%1.4%2 $262.37
2/28/20231,850,000 shares $499.24 million +8.2%1.3%1.8 $269.86
2/15/20231,710,000 shares $477.06 million -8.6%1.2%1.5 $278.98
1/31/20231,870,000 shares $543.98 million -1.1%1.3%1.6 $290.90
1/15/20231,890,000 shares $544.40 million +10.5%1.3%1.5 $288.04
12/30/20221,710,000 shares $473.53 million -18.6%1.2%1.2 $276.92
12/15/20222,100,000 shares $595.22 million -15.7%1.5%1.2 $283.44
11/30/20222,490,000 shares $759.87 million +2.5%1.7%1.4 $305.17
11/15/20222,430,000 shares $728.47 million -1.6%N/A1.5 $299.78
10/31/20222,470,000 shares $700.10 million -1.2%1.7%1.6 $283.44
10/15/20222,500,000 shares $661.58 million -7.8%1.7%1.7 $264.63
9/30/20222,710,000 shares $723.57 million +30.9%1.9%2.1 $267.00
9/15/20222,070,000 shares $427.91 million +9.5%1.4%2.2 $206.72
8/31/20221,890,000 shares $369.27 million -5.5%1.3%2 $195.38
8/15/20222,000,000 shares $444.76 million +3.1%1.4%2.1 $222.38
7/31/20221,940,000 shares $417.22 million -7.2%1.3%1.8 $215.06
7/15/20222,090,000 shares $453.55 million -17.1%1.4%1.9 $217.01
6/30/20222,520,000 shares $513.93 million -5.3%1.7%2.3 $203.94
6/15/20222,660,000 shares $524.71 million +10.4%1.8%2.4 $197.26
5/31/20222,410,000 shares $482 million +9.6%1.7%2.2 $200.00
5/15/20222,200,000 shares $438.04 million +7.8%1.5%2 $199.11
4/30/20222,040,000 shares $423.18 million +5.7%1.4%1.9 $207.44
4/15/20221,930,000 shares $410.22 million No Change1.3%1.7 $212.55
3/31/20221,930,000 shares $406.46 million -12.3%1.3%1.4 $210.60
3/15/20222,200,000 shares $434.19 million -11.3%1.5%1.4 $197.36
2/28/20222,480,000 shares $523.30 million -2.4%1.7%1.6 $211.01
2/15/20222,540,000 shares $552.12 million -13.9%1.7%1.6 $217.37
1/31/20222,950,000 shares $666.70 million +2.1%2.0%1.8 $226.00
1/15/20222,890,000 shares $691.58 million +17.5%2.0%1.9 $239.30
12/31/20212,460,000 shares $590.20 million +5.6%1.7%1.8 $239.92
12/15/20212,330,000 shares $549.60 million -2.5%1.6%2 $235.88
11/30/20212,390,000 shares $563.42 million +16.6%1.6%2.1 $235.74
11/15/20212,050,000 shares $557.23 million -13.9%1.4%2 $271.82
10/29/20212,380,000 shares $634.70 million -0.8%1.6%2.3 $266.68
10/15/20212,400,000 shares $674.86 million -3.6%1.6%2.4 $281.19
9/30/20212,490,000 shares $704.65 million +2.1%1.7%2.4 $282.99
9/15/20212,440,000 shares $730.07 million +2.5%1.6%2.1 $299.21
8/31/20212,380,000 shares $806.61 million +9.2%1.6%1.7 $338.91
8/13/20212,180,000 shares $746.11 million +21.8%1.5%1.1 $342.25
7/30/20211,790,000 shares $584.85 million -4.3%1.2%0.9 $326.73
7/15/20211,870,000 shares $613.66 million -2.6%1.2%1 $328.16
6/30/20211,920,000 shares $664.84 million -44.8%1.3%1 $346.27
6/15/20213,480,000 shares $1.38 billion +11.2%2.3%2 $396.08
5/28/20213,130,000 shares $837.21 million +3.0%2.1%1.9 $267.48
5/14/20213,040,000 shares $856.40 million -5.6%2.0%2.8 $281.71
Collect $7k per month from Tesla’s SECRET dividend (Ad)

There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?

Click here to uncover Tesla's hidden income secret.
4/30/20213,220,000 shares $854.36 million -0.6%2.1%2.9 $265.33
4/15/20213,240,000 shares $861.16 million -11.2%2.2%2.7 $265.79
3/31/20213,650,000 shares $1.01 billion -8.1%2.4%2.9 $276.01
3/15/20213,970,000 shares $1.06 billion +11.2%2.6%3 $266.13
2/26/20213,570,000 shares $989.82 million +4.4%2.4%2.8 $277.26
2/12/20213,420,000 shares $953.53 million -6.8%2.3%2.6 $278.81
1/29/20213,670,000 shares $983.08 million +0.8%2.4%2.4 $267.87
1/15/20213,640,000 shares $1.02 billion -2.4%2.4%2.1 $280.29
12/31/20203,730,000 shares $908.55 million -3.1%2.4%2.2 $243.58
12/15/20203,850,000 shares $944.21 million -7.0%2.5%2.3 $245.25
11/30/20204,140,000 shares $1.01 billion +11.6%2.7%2.5 $243.78
11/15/20203,710,000 shares $922.27 million -2.4%2.4%2.3 $248.59
10/30/20203,800,000 shares $932.82 million +26.3%2.5%2.5 $245.48
10/15/20203,010,000 shares $869.95 million +6.4%2.0%2.6 $289.02
9/30/20202,830,000 shares $802.81 million -23.3%1.8%2.5 $283.68
9/15/20203,690,000 shares $1.03 billion +11.5%2.3%3 $278.45
8/31/20203,310,000 shares $952.09 million +39.1%2.1%2.2 $287.64
8/14/20202,380,000 shares $688.89 million -6.7%1.5%1.6 $289.45
7/31/20202,550,000 shares $700.46 million -8.3%1.6%1.6 $274.69
7/15/20202,780,000 shares $781.93 million -14.7%1.8%1.7 $281.27
6/30/20203,260,000 shares $872.21 million -29.9%2.0%1.8 $267.55
6/15/20204,650,000 shares $1.29 billion +2.7%2.9%2.4 $278.49
5/29/20204,530,000 shares $1.39 billion +1.1%2.8%2.3 $307.09
5/15/20204,480,000 shares $1.42 billion +7.4%2.8%2.2 $316.60
4/30/20204,170,000 shares $1.24 billion +9.5%2.6%2 $296.83
4/15/20203,810,000 shares $1.25 billion +26.6%2.3%1.7 $326.94
3/31/20203,010,000 shares $896.38 million -15.5%1.7%1.4 $297.80
3/13/20203,560,900 shares $1.14 billion +13.4%2.1%1.9 $321.05
2/28/20203,140,000 shares $845.26 million -6.8%1.8%1.8 $269.19

BIIB Short Interest - Frequently Asked Questions

What is Biogen's current short interest?

Short interest is the volume of Biogen shares that have been sold short but have not yet been closed out or covered. As of January 31st, investors have sold 3,740,000 shares of BIIB short. 2.59% of Biogen's shares are currently sold short. Learn More on Biogen's current short interest.

What is a good short interest ratio for Biogen?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BIIB shares currently have a short interest ratio of 2.0. Learn More on Biogen's short interest ratio.

Which institutional investors are shorting Biogen?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Biogen: GTS Securities LLC, Wolverine Trading LLC, Squarepoint Ops LLC, Royal Bank of Canada, Nomura Holdings Inc., Millennium Management LLC, Group One Trading LLC, Eisler Capital Management Ltd., D. E. Shaw & Co. Inc., Cubist Systematic Strategies LLC, Caption Management LLC, Capstone Investment Advisors LLC, Citadel Advisors LLC, Bank of America Corp DE, Jane Street Group LLC, Tudor Investment Corp ET AL, Susquehanna International Group LLP, Concourse Financial Group Securities Inc., Walleye Trading LLC, Walleye Capital LLC, Barclays PLC, Capital Fund Management S.A., JPMorgan Chase & Co., Mirae Asset Securities USA Inc., Simplex Trading LLC, Twin Tree Management LP, SG Americas Securities LLC, and JPMorgan Chase & Co.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Biogen?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.59% of Biogen's floating shares are currently sold short.

Is Biogen's short interest increasing or decreasing?

Biogen saw a decrease in short interest during the month of January. As of January 31st, there was short interest totaling 3,740,000 shares, a decrease of 0.8% from the previous total of 3,770,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Biogen's float size?

Biogen currently has issued a total of 146,380,000 shares. Some of Biogen's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Biogen currently has a public float of 144,540,000 shares.

How does Biogen's short interest compare to its competitors?

2.59% of Biogen's shares are currently sold short. Here is how the short interest of companies in the industry of "biotechnology" compare to Biogen: Regeneron Pharmaceuticals, Inc. (2.00%), Alnylam Pharmaceuticals, Inc. (2.27%), United Therapeutics Co. (4.59%), Incyte Co. (3.06%), BioMarin Pharmaceutical Inc. (2.36%), Neurocrine Biosciences, Inc. (2.41%), Exelixis, Inc. (4.72%), Exact Sciences Co. (5.37%), Repligen Co. (6.38%), Halozyme Therapeutics, Inc. (7.22%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.21 billion), Charter Communications, Inc. ($4.07 billion), Reddit, Inc. ($3.33 billion), The Kroger Co. ($2.67 billion), Cencora, Inc. ($2.29 billion), Hims & Hers Health, Inc. ($2.17 billion), SoFi Technologies, Inc. ($1.99 billion), Live Nation Entertainment, Inc. ($1.87 billion), Rivian Automotive, Inc. ($1.76 billion), and Moderna, Inc. ($1.60 billion). View all of the most shorted stocks.

What does it mean to sell short Biogen stock?

Short selling BIIB is an investing strategy that aims to generate trading profit from Biogen as its price is falling. BIIB shares are trading up $3.56 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Biogen?

A short squeeze for Biogen occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BIIB, which in turn drives the price of the stock up even further.

How often is Biogen's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BIIB, twice per month. The most recent reporting period available is January, 31 2025.



Related Companies
Short Interest Tools

This page (NASDAQ:BIIB) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners
Secret financial plot unfolding in Washington DC… [DEVELOPING]
What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...
Timothy Sykes | Sponsored
Buy this AI Stock Before Elon’s Announcement
With Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...
InvestorPlace | Sponsored
[RFK Jr CONFIRMED] Here’s why Dems are TERRIFIED
Robert F. Kennedy Jr was just confirmed as Trump’s secretary of Health and Human Services… but it was NOT easy...
NewMarket Health Publishing, LLC. | Sponsored
Elon’s “New Gold”
MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...
True Market Insiders | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
What is this southern state hiding?
The financial press had a field day this week after President Donald Trump and Department of Government Effici...
Stansberry Research | Sponsored
Elon Takes Aim at Social Security
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...
Altimetry | Sponsored
Nvidia’s Next Big Move Comes on Feb. 26
Nvidia isn't the only company that benefits greatly from these earnings calls. That's because a handful of ...
Weiss Ratings | Sponsored